Nicotine's effect on depression in brain imaging study
Part of Mental health clinical trials.
This trial uses a special brain scan to see how nicotine might help treat depression. It compares people with depression to healthy volunteers to understand how nicotine affects brain chemistry related to mood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have not used any nicotine products (like cigarettes, e-cigarettes, patches, or gum) in the past year, unless you only use them occasionally and can stop for at least a week before the scan.
- If you have depression: your depression must be your main diagnosis and you must currently be in a major depressive episode with a score of at least 29 on a standard depression rating scale.
- You cannot be taking medications that affect a brain chemical called acetylcholine, or certain antidepressants.
- You cannot have serious medical conditions, eye problems like keratoconus, or metal in your body that would prevent an MRI or PET scan.
- You must not be pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how a specific brain receptor related to pain signals (nociceptin/orphanin FQ receptor) may be involved in depression. It may help researchers understand depression better by comparing people with current versus past (remitted) major depression.
This trial tests different targets for repetitive transcranial magnetic stimulation (rTMS)—a non-surgical brain stimulation—to change brain “reward” activity in people who are nicotine dependent. If you qualify, you may receive sessions of brain stimulation as the researchers look for the best brain target.
This study tests how nicotine affects the brain's reward system in people who smoke. It aims to find the level of nicotine that becomes addictive, helping guide future treatments.
This study looks at how a non-invasive brain stimulation technique called TMS (which uses magnetic pulses to stimulate the brain) might affect the brain's reward system in people who smoke. The goal is to understand how to help people quit smoking more effectively.
This study uses brain scans to understand how substance use and mental illness, like depression, are linked. It may help develop better treatments by looking at brain activity in people with and without depression.
This study tests whether a brain stimulation treatment called rTMS can help people with psychiatric conditions quit smoking. You will be randomly assigned to get either rTMS or a nicotine patch, and your progress will be tracked to see which treatment works better.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.